Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,262.56 89.32 0.55%
S&P 500 1,842.98 12.37 0.68%
NASDAQ 4,034.16 11.47 0.29%
Ticker Volume Price Price Delta
STOXX 50 3,091.52 -40.05 -1.28%
FTSE 100 6,541.61 -42.15 -0.64%
DAX 9,173.71 -165.46 -1.77%
Ticker Volume Price Price Delta
NIKKEI 14,378.48 381.67 2.73%
TOPIX 1,163.67 27.58 2.43%
HANG SENG 22,837.73 166.47 0.73%

Michael V. Seiden, M.D., Ph.D. Appointed Chief Medical Officer for McKesson Specialty Health and The US Oncology Network



  Michael V. Seiden, M.D., Ph.D. Appointed Chief Medical Officer for McKesson
  Specialty Health and The US Oncology Network

Business Wire

THE WOODLANDS, Texas -- August 28, 2013

McKesson Specialty Health and The US Oncology Network today announced the
appointment of Michael V. Seiden, M.D., Ph.D. as chief medical officer,
effective September 22. This appointment is the next step in the
organization’s continued drive towards becoming the clear leader in empowering
the delivery of high-quality, evidence-based, cost-effective care.

“Dr. Seiden’s distinguished track record and extensive experience across
patient care, research and operations makes him uniquely qualified to lead our
organization’s clinical and physician engagement strategy,” said Marc Owen,
president, McKesson Specialty Health. “His experience as a practicing
oncologist and in running a major cancer center will complement the existing
leadership team and ensure that a physician’s perspective is contemplated in
all decisions.”

“Dr. Seiden’s expertise will be beneficial in driving The US Oncology
Network’s vision of improving patient outcomes and quality of life,” said
Steven Paulson, M.D., president and chairman of the board for Texas Oncology,
a practice affiliated with The US Oncology Network. “Physicians from The US
Oncology Network participated in the candidate search which led to Dr.
Seiden’s appointment, and we are pleased to welcome him to the organization.”

As the Chief Medical Officer, Dr. Seiden will lead McKesson Specialty Health’s
clinical strategy and work closely with physicians in The US Oncology Network
and other community practices across the country to enhance the delivery of
high-quality, evidence-based care.

“McKesson Specialty Health and The US Oncology Network’s commitment to
empowering the community patient care delivery system through a
physician-driven approach is vital given today’s rapidly-changing
environment,” said Dr. Seiden. “I look forward to working closely with this
team to ensure that patients everywhere have access to the best care
possible.”

Until recently, Dr. Seiden served as the CEO and President of Fox Chase Cancer
Center, a National Cancer Institute-designated Comprehensive Cancer Center
research facility and hospital in Philadelphia, Penn., and one of the
top-ranked cancer programs in the country. Under his leadership, Fox Chase
merged with Temple University Health system in 2012. Prior to Fox Chase, Dr.
Seiden spent many years practicing at Massachusetts General Hospital, where he
served as Chief of the Clinical Research Unit, Cancer Science Division. A
nationally known expert on ovarian cancer, Dr. Seiden has been a practicing
oncologist for more than 20 years.

Dr. Seiden received his bachelor’s degree from Oberlin College and his medical
and Ph.D. degrees from Washington University. He completed his residency at
Massachusetts General Hospital, his fellowships in medical oncology and bone
marrow transplant at Dana Farber Cancer Institute, and his post-doctoral
fellowship at Brigham and Women’s Hospital, Department of Pathology. He will
be based in The Woodlands, Texas.

About McKesson Specialty Health

McKesson Specialty Health, a division of McKesson Corporation, empowers the
community patient care delivery system by helping community practices advance
the science, technology and quality of care. Through innovative clinical,
research, business and operational solutions, facilitated by integrated
technology systems, we focus on improving the financial health of our
customers so they may provide the best care to their patients. For more
information, visit www.mckessonspecialtyhealth.com.

About The US Oncology Network

The US Oncology Network is one of the nation’s largest networks of integrated,
community-based oncology practices dedicated to advancing high-quality,
evidence-based cancer care. A physician-led organization, The US Oncology
Network unites like-minded physicians and clinicians around a common vision of
improving patient outcomes and quality of life. Leveraging healthcare
information technology, shared best practices, evidence-based guidelines and
quality measurements, physicians within The US Oncology Network are pioneering
new ways to achieve this vision. The US Oncology Network is committed to
strengthening patient access to integrated care in local communities across
the nation, including collaboration with a variety of payers, hospitals and
academic institutions. The US Oncology Network is supported by McKesson
Specialty Health, a division of McKesson Corporation focused on empowering a
vibrant and sustainable community patient care delivery system. For more
information, visit www.usoncology.com.

Contact:

McKesson Specialty Health
Claire Crye, 281-863-6783
claire.crye@mckesson.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement